Skip to content

Tetroxoprim

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: piritrexin

ATC J01EE06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tetroxoprim is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including folA, folA and dfrA17.

  • Molecular targets: folA, folA, dfrA17 and folA (4 listed in DrugCentral).
  • ATC code: J01EE06 (Combinations of sulfonamides and trimethoprim, incl. derivatives).
  • Molecular formula: C16H22N4O4; molecular weight 334.38 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Dihydrofolate reductasefolAunknownKi 8.35
Dihydrofolate reductasefolAunknownKi 8.35
Dihydrofolate reductasedfrA17unknownIC50 7.74
Dihydrofolate reductasefolAunknownKi 6.26

ATC classification

ATC codeTherapeutic hierarchy
J01EE06ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Combinations of sulfonamides and trimethoprim, incl. derivatives

Chemical structure

Molecular formulaC16H22N4O4
Molecular weight334.38 g/mol
CAS number53808-87-0
InChIKeyWSWJIZXMAUYHOE-UHFFFAOYSA-N
PubChem CID65450
COCCOC1=C(OC)C=C(CC2=CN=C(N)N=C2N)C=C1OC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Tetroxoprim work?

Its molecular targets in DrugCentral include folA, folA, dfrA17 and folA.

What is the chemical formula of Tetroxoprim?

Tetroxoprim has the molecular formula C16H22N4O4 and a molecular weight of 334.38 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets4
Indications0
FormulaC16H22N4O4
DrugCentral ID2615
Interactive profile